Frequency ExchangeFRECF -32.52%8 12-1 Month Momentum % is 50.00% as of Jul. 05, 2026. GuruFocus rates FRECF with a GF Score™ of 8/100 and a GF Value™ of $0.07 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 824 Medical Devices & Instruments companies, Frequency Exchange ranks better than 70.63% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-07-05), Frequency Exchange's 12-1 Month Momentum % is 50.00%.
The industry rank for Frequency Exchange's 12-1 Month Momentum % or its related term are showing as below:
FRECF's 12-1 Month Momentum % is ranked better than 70.63% of 824
companies
in the Medical Devices & Instruments industry
Industry Median: -13.165
vs FRECF: 50.00
Frequency Exchange (OTCPK:FRECF) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Frequency Exchange 12-1 Month Momentum % Related Terms
FRECF vs ABT, SYK, MDT: 12-1 Month Momentum % Comparison
For the Medical Devices subindustry, Frequency Exchange's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Frequency Exchange 12-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Frequency Exchange's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Frequency Exchange's 12-1 Month Momentum % falls into.
Frequency Exchange (OTCPK:FRECF) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Frequency Exchange (FRECF) has a 12-1 Month Momentum % of 50.00% as of Jul. 05, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Frequency Exchange and its competitors. According to the industry distribution chart, Frequency Exchange ranks #242 out of 824 companies in the Medical Devices & Instruments industry, placing it in the top 29.4%.
Is Frequency Exchange's 12-1 Month Momentum % too high?
Frequency Exchange's current 12-1 Month Momentum % is 50.00%. Based on the distribution chart, Frequency Exchange ranks #242 out of 824 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Frequency Exchange has a GF Score™ of 8/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Frequency Exchange's 12-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Frequency Exchange ranks #242 out of 824 companies for 12-1 Month Momentum %. This puts Frequency Exchange in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Medical Devices & Instruments company?
A good 12-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Frequency Exchange and its competitors. Frequency Exchange's current 12-1 Month Momentum % is 50.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frequency Exchange stock overvalued right now?
Based on GuruFocus' analysis, Frequency Exchange (FRECF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.07, compared to a current price of $0.16 — trading 128.6% above its estimated fair value. The current 12-1 Month Momentum % is 50.00%. Frequency Exchange's overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Frequency Exchange (FRECF), the current 12-1 Month Momentum % is 50.00% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Frequency Exchange (FRECF) Overvalued in 2026?
Based on GuruFocus' analysis, Frequency Exchange stock appears to be overvalued.
The current stock price of $0.16 is trading 128.6% above its estimated GF Value™ of $0.07.
GuruFocus considers Frequency Exchange to be Significantly Overvalued.
Key valuation signals for FRECF:
12-1 Month Momentum %: 50.00%
GF Value™: $0.07 vs. price of $0.16 (128.6% above fair value)
No single metric tells the full story. See the FRECF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Frequency Exchange Corp is focused on the development and world-wide commercialization of a wearable Frequency Delivery System providing specialized programs designed for health and wellness as well as performance enhancement. The company has one operating and reportable segment which the sale of wearable devices. Geographically, it operates in Canada; United States; and International.
8GF Score
Get the complete analysis for FRECF
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRECF has been successfully added to your 